-
Mashup Score: 3The Innovation Wave | LinkedIn - 4 year(s) ago
¿Quieres conocer la relación entre las olas del mar y la innovación en Novartis? Sesión inaugural del evento The Innovation Wave. “The Innovation Wave” es el movimiento de transformación digital que Novartis España ha lanzado en el ámbito de la salud y que nos ha permitido poder avanzar de una manera ágil en mejorar y prolongar la vida de los pacientes. Este programa tiene como objetivo…
Source: www.linkedin.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Nursing in Practice Event Registration - 4 year(s) ago
Thank you for your interest in Nursing in Practice.Please fill in the form below to secure your place today. If you have any problems, you can contact us at events@cogora.com Are you a ‘health professional’ (this includes members of the medical, dental, pharmacy and nursing professions and any other persons who in the course of their professional activities may administer, prescribe, purchase,…
Source: www.tfaforms.comCategories: Latest Headlines, NursingTweet-
Join us today at the Nursing n Practice Virtual Festival to watch #Novartis live as they talk about treating lipids in the community. It is not too late to register for free: https://t.co/hKF18reLbw #NIPVirtual Festival #Healthcareshow https://t.co/uc2BCd5sQs
-
-
Mashup Score: 2
Secukinumab, an IL-17a inhibitor currently approved in the United States for moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis, has been approved by the U.S. Food and Drug Administration for the treatment of active non-radiographic axial spondyloarthritis.
Source: Rheumatology NetworkCategories: Latest Headlines, RheumatologyTweet-
Secukinumab Approved for Active Non-radiographic Axial Spondyloarthritis #novartis #cosentyx #secukinumab #novartisnews https://t.co/mmt9De8Pce https://t.co/L3II8JPGfe
-
-
Mashup Score: 0Cancer: Vol 126, No S10 - 4 year(s) ago
Click on the title to browse this issue
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Don’t miss a special supplement from Cancer - Improving Breast Health Care Through Resource-Stratified Phased Implementation by guest editor, Dr. Benjamin O. Anderson, BHGI Chair and Director: https://t.co/yCP2TfZPTo Support provided by #novartis #gehealthcare https://t.co/HgZw73QKxU
-
-
Mashup Score: 0Cancer: Vol 126, No S10 - 4 year(s) ago
Click on the title to browse this issue
Source: American Cancer Society JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Don’t miss a special supplement from Cancer - Improving Breast Health Care Through Resource-Stratified Phased Implementation by guest editor, Dr. Benjamin O. Anderson, BHGI Chair and Director. Support for this supplement provided by #novartis #gehealthcare https://t.co/S0w4704E0g https://t.co/3HVKkwDCdA
-
-
Mashup Score: 0
Novartis has reached an agreement with the FDA clearing the way for the company to sponsor a large clinical trial studying the use of hydroxychloroquine among hospitalized patients with COVID-19, according to a press release.The phase 3 trial will recruit approximately 440 participants across more than a dozen sites in the United States, with enrollment scheduled to begin in the next few weeks,
Source: bit.lyCategories: Latest Headlines, RheumatologyTweet-
Dr. Alfred Kim @WUSTLmed applauds #Novartis joining the effort to test #Hydroxychloroquine for #COVID19 but maintains concerns regarding the drug's overuse as a preventative measure https://t.co/VYrryuKFuQ https://t.co/2ZrBmmOe5U
-
The Novartis Innovation Wave is tomorrow! The team would LOVE a shout out from @VasNarasimhan! https://t.co/RvfcfvVW9T @NovartisSpain @Novartis #digitalhealth #healthtech #Novartis